According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various healthcare sectors in the U.S. during the next four years, including a major North Carolina facility. That would mark an increase of 25 percent compared with the previous four years.

The investments will be spread across research and development, innovation powerhouse, announced manufacturing, and technology. This is headlined by a $2 billion biologics manufacturing development facility in Wilson, North Carolina, which recently broke the ground. The 500,000-square-foot site is expected to create 5,000 jobs during the construction phase and more than 500 employment opportunities in the state. Moreover, it is set to expand medication capacity for those with neurological diseases and cancer and provide an estimated $3 billion economic impact during the first decade open in North Carolina.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2025 ALM Global, LLC. All Rights Reserved.